The Population Council has conducted more than 20 clinical trials between 2010 to 2018, and has several planned for 2019. We’re testing new technologies – including rings, gels, tablets, fast-dissolving inserts and other innovative delivery systems – designed to safely prevent pregnancy and sexually transmitted infections at lower-cost, with fewer side effects, and offering multiple benefits.
Featured products under development:
Nestorone/ testosterone gel
Population Council’s Regine Sitruk-Ware, in collaboration with the Eunice Kennedy Shriver National Institute of Child Health and Human Development, is co-directing a Phase IIb clinical trial of a Nestorone-Testosterone gel as a contraceptive for men, the first to test the new reversible contraceptive on the prevention of unintended pregnancy.
The Population Council has been a leader in the research and development of microbicides since the 1990s. Today, we’re developing a griffithsin-containing microbicide to prevent the transmission of HIV and other sexually transmitted infections. Griffithsin is a naturally occurring protein isolated from algae that has potent activity against HIV, herpes simplex virus, and human papilloma virus, and more.
Multipurpose prevention technologies
Scientists are investigating new approaches to prevent HIV and other sexually transmitted infections (STIs) and developing next-generation contraceptives and novel multi-purpose prevention technologies, or MPTs, which are designed to prevent HIV, other STIs and, in some cases, unintended pregnancy in a single product.